MILTOWN |
TRANMEP |
EQUANIL |
AMOSENE |
MEPROBAMATE |
MEPRIAM |
NEURAMATE |
TENAVOID |
BAMATE |
MEPROSPAN |
MEPROBAMATUM |
MEPROBAMIC ACID |
EQUANIL® |
MEPROBAMAT |
MEPROBAMATO |
MILTOWN® |
MEPROSPAN® |
chemidplus:57-53-4 |
pubchem.compound:4064 |
rxcui:6760 |
chembl:CHEMBL979 |
drugbank:00371 |
FDA Approval | Approved before 1982 |
Drug Class | small molecule |
Drug Indications | Hypnotics and Sedatives |
Drug Indications | Anticonvulsants |
Drug Class | anticonvulsants |
Drug Class | hypnotics and sedatives |
Year of Approval | approved before 1982 |
positive modulator (activating) |
agonist (activating) |
Direct Interaction | yes |
Mechanism of Interaction | GABA-A receptor; anion channel agonist |
Trial Name | - |
agonist (activating) |
Direct Interaction | yes |
Mechanism of Interaction | GABA-A receptor; anion channel agonist |
Trial Name | - |
agonist (activating) |
Direct Interaction | yes |
Mechanism of Interaction | GABA-A receptor; anion channel agonist |
Trial Name | - |
agonist (activating) |
Novel drug target | Established target |
Trial Name | - |
Mechanism of Interaction | GABA-A receptor; anion channel agonist |
agonist (activating) |
Mechanism of Interaction | GABA-A receptor; anion channel agonist |
Direct Interaction | yes |
Trial Name | - |
agonist (activating) |
Trial Name | - |
Novel drug target | Established target |
Mechanism of Interaction | GABA-A receptor; anion channel agonist |
agonist (activating) |
Direct Interaction | yes |
Mechanism of Interaction | GABA-A receptor; anion channel agonist |
agonist (activating) |
Mechanism of Interaction | GABA-A receptor; anion channel agonist |
Direct Interaction | yes |
agonist (activating) |
Direct Interaction | yes |
Mechanism of Interaction | GABA-A receptor; anion channel agonist |
agonist (activating) |
Mechanism of Interaction | GABA-A receptor; anion channel agonist |
Direct Interaction | yes |
agonist (activating) |
Direct Interaction | yes |
Mechanism of Interaction | GABA-A receptor; anion channel agonist |
agonist (activating) |
Mechanism of Interaction | GABA-A receptor; anion channel agonist |
Direct Interaction | yes |
agonist (activating) |
Mechanism of Interaction | GABA-A receptor; anion channel agonist |
Direct Interaction | yes |
agonist (activating) |
Mechanism of Interaction | GABA-A receptor; anion channel agonist |
Direct Interaction | yes |
agonist (activating) |
Mechanism of Interaction | GABA-A receptor; anion channel agonist |
Direct Interaction | yes |
agonist (activating) |
Direct Interaction | yes |
Mechanism of Interaction | GABA-A receptor; anion channel agonist |
MEPROBAMATE | Primary Drug Name |
Year of Approval | approved before 1982 |
Drug Class | hypnotics and sedatives |
Drug Class | anticonvulsants |
Drug Indications | Anticonvulsants |
Drug Indications | Hypnotics and Sedatives |
Drug Class | small molecule |
D0Y4AW | TTD Drug ID |